Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Federal Trade Commission
Cantor Fitzgerald
McKesson
Covington
Queensland Health
Fuji
Accenture
Farmers Insurance

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019292

« Back to Dashboard

NDA 019292 describes MD-76R, which is a drug marketed by Liebel-flarsheim and is included in one NDA. It is available from one supplier. Additional details are available on the MD-76R profile page.

The generic ingredient in MD-76R is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for 019292
Tradename:MD-76R
Applicant:Liebel-flarsheim
Ingredient:diatrizoate meglumine; diatrizoate sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019292
Mechanism of ActionX-Ray Contrast Activity
Suppliers and Packaging for NDA: 019292
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MD-76R diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 019292 NDA Liebel-Flarsheim Company LLC 0019-1317 0019-1317-09 12 BOTTLE, GLASS in 1 BOX (0019-1317-09) > 200 mL in 1 BOTTLE, GLASS
MD-76R diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 019292 NDA Liebel-Flarsheim Company LLC 0019-1317 0019-1317-07 12 BOTTLE, GLASS in 1 BOX (0019-1317-07) > 100 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength66%;10%
Approval Date:Sep 29, 1989TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Colorcon
Citi
Harvard Business School
McKinsey
Baxter
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot